Skip to main content
. 2015 Sep 25;4:234–242. doi: 10.1016/j.bbrep.2015.09.017

Fig. 2.

Fig. 2

Structures of siastatin B (6-acetamido-3-piperidine carboxylate) [18] (A) and DANA (2-deoxy-2,3-dehydro-N-acetylneuraminic acid) [11] (B). M.F.: Molecular formula; M.W.: Molcular weight. Inhibitory effects of siastatin B (6-acetamido-3-piperidine carboxylate) and DANA (2,3-didehydro-2-deoxy-N-acetylneuraminic acid) on 4MU-NANA-degrading activity of recombinant human NEU2 at pH 6.0 (C) and pH 4.0 (D), and on α2,3-sialyllactose-degrading activity at pH 6.0 and 4.0 (E).